Bicocca Open Archive

Logo unimib boa
ARCANGELI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.456
EU - Europa 3.388
AS - Asia 1.919
SA - Sud America 95
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 11.889
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.384
SG - Singapore 828
IT - Italia 808
RU - Federazione Russa 681
IE - Irlanda 617
HK - Hong Kong 598
DE - Germania 508
CN - Cina 351
SE - Svezia 321
GB - Regno Unito 125
UA - Ucraina 123
BR - Brasile 80
FR - Francia 66
CA - Canada 57
VN - Vietnam 41
ID - Indonesia 38
NL - Olanda 33
FI - Finlandia 26
IN - India 22
AT - Austria 21
MX - Messico 13
TR - Turchia 13
DK - Danimarca 11
CZ - Repubblica Ceca 7
ES - Italia 7
ZA - Sudafrica 7
AR - Argentina 5
EG - Egitto 5
GR - Grecia 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
IR - Iran 4
MA - Marocco 4
PT - Portogallo 4
SA - Arabia Saudita 4
BO - Bolivia 3
EU - Europa 3
JO - Giordania 3
LT - Lituania 3
PL - Polonia 3
RO - Romania 3
SC - Seychelles 3
AL - Albania 2
AU - Australia 2
BE - Belgio 2
BG - Bulgaria 2
CL - Cile 2
DZ - Algeria 2
EC - Ecuador 2
IQ - Iraq 2
KE - Kenya 2
LV - Lettonia 2
SI - Slovenia 2
AO - Angola 1
AZ - Azerbaigian 1
BD - Bangladesh 1
GT - Guatemala 1
JM - Giamaica 1
JP - Giappone 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 11.889
Salva come PNG Salva come JPEG
Città #
Fairfield 1.047
Ann Arbor 823
Dublin 612
Hong Kong 593
Ashburn 520
Singapore 508
Frankfurt am Main 431
Woodbridge 429
Seattle 407
Wilmington 402
Santa Clara 342
Cambridge 341
Houston 341
Princeton 237
New York 183
Milan 180
Chandler 122
Altamura 110
Lawrence 108
Dearborn 89
Jacksonville 87
San Diego 69
Moscow 68
Nanjing 67
Rome 57
Andover 41
Jakarta 35
Beijing 34
Shanghai 33
Toronto 29
Dong Ket 26
Ottawa 26
Guangzhou 24
Hebei 24
London 24
Helsinki 22
Nanchang 22
Shenyang 22
Los Angeles 17
Xi'an 15
Jiaxing 14
Nuremberg 14
Jinan 12
Lissone 12
Fremont 11
Pune 11
Chicago 10
Council Bluffs 10
Mexico City 10
Redmond 10
Sulzano 10
Cologna Veneta 9
Monza 9
Munich 9
Norwalk 9
Palermo 9
Vienna 9
Bari 8
Changsha 8
Brescia 7
Madrid 7
Olomouc 7
Zhengzhou 7
Anzio 6
Genoa 6
Naples 6
São Paulo 6
Tianjin 6
Verona 6
Athens 5
Cagliari 5
Huizen 5
Kiev 5
Kunming 5
San Mateo 5
Al Qāhirah al Jadīdah 4
Belo Horizonte 4
Berlin 4
Boardman 4
Chiswick 4
Dallas 4
Falls Church 4
Fuzhou 4
Hefei 4
Messina 4
Nave 4
Perugia 4
Sesto San Giovanni 4
Turin 4
Amantea 3
Amman 3
Boulder 3
Brasília 3
Bucharest 3
Des Moines 3
Florence 3
Kocaeli 3
La Paz 3
Lainate 3
Lappeenranta 3
Totale 8.944
Salva come PNG Salva come JPEG
Nome #
Effetti immunologici della radioterapia 410
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 267
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 254
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 247
Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: A secondary analysis from a randomized study 198
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 185
Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic 179
Optimal scheduling of hypofractionated radiotherapy for localized prostate cancer: A systematic review and metanalysis of randomized clinical trials 167
Association between treatment-related lymphopenia and survival in glioblastoma patients following postoperative chemoradiotherapy 161
Moderate hypofractionated helical tomotherapy for localized prostate cancer: preliminary report of an observational prospective study 157
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 143
Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer 134
Phase I-II study of intraoperative radiation therapy (IORT) after radical prostatectomy for prostate cancer 133
Attitudes, practices and perspectives on imaging strategies in prostate cancer: a national cross-sectional survey involving expert radiation oncologists on behalf of AIRO (Italian association of radiotherapy and clinical oncology) GU group 129
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 126
GUROPA survey: genito-urinary radiation oncology prescription attitudes 125
Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area 123
Toxicity and cosmesis outcomes after single fraction partial breast irradiation in early stage breast cancer 123
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 123
1539 poster TUMOR CONTROL PROBABILITY IN STEREOTACTIC RADIO-SURGERY FOR BRAIN METASTASES 121
Moderate hypofractionation in high-risk, organ-confined prostate cancer: Final results of a phase III randomized trial 120
Epidemiology of prostate cancer and treatment remarks. 120
Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial 119
Almost one year of COVID-19 pandemic: how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study 119
DVHs evaluation in brain metastases stereotactic radiotherapy treatment plans 117
Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists 117
Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials 116
Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer 115
International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV study 114
Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC 114
Mathematical Model for Evaluating Incidence of Acute Rectal Toxicity During Conventional or Hypofractionated Radiotherapy Courses for Prostate Cancer 114
Postoperative Hypofractionated Radiotherapy for Prostate Cancer 111
Accelerated hyperfractionated radiotherapy and concurrent protracted venous infusion chemotherapy in locally advanced head and neck cancer 111
Treatment outcomes and patterns of radiologic appearance after hypofractionated image-guided radiotherapy delivered with helical tomotherapy (HHT) for lung tumours 110
Moderate hypofractionation for prostate cancer 110
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer 109
Consolidative ablative radiotherapy improves outcomes in oligometastatic non-small cell lung cancer: A further step toward new evidence 108
Hypofractionated radiotherapy for organ-confined prostate cancer: Is less more? 108
Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: report on acute toxicity 108
Combination of androgen deprivation therapy and radiotherapy for localized prostate cancer in the contemporary era 107
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 104
Clinical and Dosimetric Predictors of Acute Toxicity After a 4-Week Hypofractionated External Beam Radiotherapy Regimen for Prostate Cancer: Results From a Multicentric Prospective Trial 104
Can volumetric modulated arc therapy with flattening filter free beams play a role in stereotactic body radiotherapy for liver lesions? A volume-based analysis. 104
A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC) 104
Extreme hypofractionation for early prostate cancer: Biology meets technology 103
Macroscopic Hematuria After Conventional or Hypofractionated Radiation Therapy: Results From a Prospective Phase 3 Study 103
"Hit the primary": A paradigm shift in the treatment of metastatic prostate cancer? 103
EORTC radiation proctitis-specific quality of life module - pretesting in four European countries 103
Updated Results and Pattern of Failure in a Randomized Hypofractionation Trial for High-risk Prostate Cancer 103
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease 102
Color Doppler quantitative measures to predict outcome of biopsies in prostate cancer 101
Inter-observer variability in the delineation of pharyngo-laryngeal tumor, parotid glands and cervical spinal cord: comparison between CT-scan and MRI 101
Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: A review. 101
Retreatment for prostate cancer with stereotactic body radiation therapy (SBRT): Feasible or foolhardy? 101
Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial 100
Stereotactic body radiation therapy salvage reirradiation of radiorecurrent prostatic carcinoma relapsed in the prostatic bed 100
Hypofractionated high-dose radiation therapy for prostate cancer: long-term results of a multi-institutional phase II trial. 100
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective 99
Re-irradiation with curative intent in patients with squamous cell carcinoma of the head and neck: a national survey of usual practice on behalf of the Italian Association of Radiation Oncology (AIRO) 99
Dose-escalated Radiotherapy for Stage III Unresectable Non-small Cell Lung Cancer: Have We Come to a Standstill? 98
Safety culture to improve accidental event reporting in radiotherapy 97
Stereotactic body radiation therapy for liver tumours using flattening filter free beam: dosimetric and technical considerations 96
A Systematic Review of Radical Cystectomy Versus Organ Preserving Trimodal Therapy in Muscle-Invasive Bladder Cancer 95
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments. 95
Radiation therapy does not increase survival in addition to standard androgen deprivation therapy for metastatic prostate cancer: An old, faded picture? 94
Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of developing erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery 94
Toxicity of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: a potential comparison bias 94
From radiobiology to technology: what is changing in radiotherapy for prostate cancer 94
Re-irradiation for esophageal cancer 92
Moderately escalated hypofractionated (chemo) radiotherapy delivered with helical intensity-modulated technique in stage III unresectable non-small cell lung cancer 92
Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer 91
Hypofractionation and Stereotactic Treatment: Clinical Data 91
Moderately escalated hypofractionated (chemo) radiotherapy delivered with helical intensity-modulated technique in stage III unresectable non-small cell lung cancer 91
Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study. 91
Stage-I small cell lung cancer: A new potential option for stereotactic ablative radiation therapy? A review of literature 89
Review and uses of stereotactic body radiation therapy for oligometastases 88
Intensity-modulated pelvic radiation therapy and simultaneous integrated boost to the prostate area in patients with high-risk prostate cancer: a preliminary report of disease control 87
Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments 85
Vertebral metastases reirradiation with volumetric-modulated arc radiotherapy 85
Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review 84
Is Hypofractionated (Chemo) radiation Delivered With Helical Tomotherapy a Feasible Option to Escalate the Dose in Locally- Advanced Inoperable NSCLC?: Results From a Phase 2 Trial 84
High-dose-rate brachytherapy as monotherapy for localized prostate cancer using three different doses - 14 years of single-centre experience 83
Radiation therapy of breast cancer. Reasoned approach to a clinical case 78
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 73
Underlying anatomy for CTV contouring and lymphatic drainage in rectal cancer radiation therapy 73
Re: Cesare Cozzarini, Claudio Fiorino, Chiara Deantoni, et al. Higher-than-expected severe (grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients 72
Stereotactic Body Radiation Therapy With Ablative Dose on Liver Metastases: Radiation-induced Liver Disease (RILD) and Toxicity Assessment 71
Re: Nazareno Suardi, Andrea Gallina, Giuliana Lista, et al. Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy 71
External beam radiation therapy in the treatment of the prostate adenocarcinoma in the elderly 68
Dose and volume as predictive factors of pulmonary toxicity 65
Guidelines on prostate carcinoma - AIRO, 2016 65
A Multicenter Large Retrospective Database on the Personalization of Stereotactic Ablative Radiotherapy for Lung Metastases From Colon-Rectal Cancer: The LaIT-SABR Study 65
Single fraction partial breast irradiation in prone position 61
The role of palliative radiotherapy in the management of elderly and frail patients with advanced bladder cancer: A survey by the AIRO uro-group 60
Treatment outcome and compliance to dose-intensified linac-based SBRT for unfavorable prostate tumors using a novel real-time organ-motion tracking 60
Management of patients with extensive small-cell lung cancer in the immunotherapy era: an Italian consensus through a Delphi approach 58
Post-operative management of brain metastases: GRADE-based clinical practice recommendations on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 56
Principi di Radioterapia 55
Hypofractionated Dose Escalated 3D Conformal Radiotherapy for Prostate Cancer: Outcomes from a Mono-Institutional Phase II Study 55
An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiation 55
Totale 10.958
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.198
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020320 0 0 0 0 0 0 0 0 0 106 155 59
2020/20211.701 74 89 187 196 195 137 150 199 105 135 115 119
2021/20221.056 83 133 115 49 27 53 42 178 41 35 88 212
2022/20231.648 275 484 194 75 69 271 30 56 100 15 48 31
2023/20241.502 30 23 34 144 164 358 385 29 169 26 32 108
2024/20253.287 148 583 159 142 278 93 513 192 525 654 0 0
Totale 12.668